Health2047 spins out Medicare Advantage company Zing Health

Healthcare innovation company Health2047 has spun out Zing Health, a tech-enabled Medicare Advantage plan meant for those traditionally underserved by existing healthcare plans. Menlo Park, California-based Health2047...

FDA rejection of Sarepta drug a ‘slap on the wrist’ over earlier approval, analyst...

The Food and Drug Administration’s rejection Monday of Sarepta Therapeutics’ second drug for Duchenne muscular dystrophy came as a surprise to many. It also led investment...

FDA gives thumbs down to Sarepta’s next Duchenne’s muscular dystrophy drug

A new drug for Duchenne muscular dystrophy failed to win Food and Drug Administration approval Monday. Cambridge, Massachusetts-based Sarepta Therapeutics said that it had received a complete...

Ciitizen launches scorecard to rate providers on patient data access

The concern over healthcare data breaches and healthcare data privacy has added to the growing movement toward individual patient control over their own data. Silicon Valley startup...

FDA approves AbbVie rheumatoid arthritis drug

The Food and Drug Administration has approved a new drug for rheumatoid arthritis made by AbbVie. The Chicago-based drugmaker said Friday that the FDA had approved Rinvoq...

Must Read